Ignite Creation Date:
2025-12-24 @ 7:25 PM
Ignite Modification Date:
2025-12-29 @ 10:13 PM
Study NCT ID:
NCT00780403
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2008-10-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Sponsor:
Organon and Co
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-08
Start Date Type:
None
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2008-10-23
First Submit QC Date:
None
Study First Post Date:
2008-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2010-02-17
Results First Submit QC Date:
None
Results First Post Date:
2010-07-30
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-07
Last Update Post Date:
2022-02-09
Last Update Post Date Type:
ACTUAL